Incyte's Accumulated Expenses fell 1591.49% to $948.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $948.4 million, marking a year-over-year decrease of 1591.49%. This contributed to the annual value of $1.2 billion for FY2024, which is 2955.2% up from last year.
Per Incyte's latest filing, its Accumulated Expenses stood at $948.4 million for Q3 2025, which was down 1591.49% from $857.1 million recorded in Q2 2025.
Over the past 5 years, Incyte's Accumulated Expenses peaked at $1.4 billion during Q1 2025, and registered a low of $413.1 million during Q2 2021.
In the last 5 years, Incyte's Accumulated Expenses had a median value of $820.6 million in 2023 and averaged $816.2 million.
As far as peak fluctuations go, Incyte's Accumulated Expenses soared by 4522.61% in 2022, and later plummeted by 1713.42% in 2025.
Over the past 5 years, Incyte's Accumulated Expenses (Quarter) stood at $533.6 million in 2021, then skyrocketed by 31.38% to $701.1 million in 2022, then surged by 33.45% to $935.6 million in 2023, then grew by 29.55% to $1.2 billion in 2024, then dropped by 21.75% to $948.4 million in 2025.
Its Accumulated Expenses stands at $948.4 million for Q3 2025, versus $857.1 million for Q2 2025 and $1.4 billion for Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value